AAAAAA

   
Results: 1-12 |
Results: 12
Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapy
Authors: Leung, NWY Lai, CL Chang, TT Guan, R Lee, CM Ng, KY Lim, SG Wu, PC Dent, JC Edmundson, S Condreay, LD Chien, RN
Citation: Nwy. Leung et al., Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapy, HEPATOLOGY, 33(6), 2001, pp. 1527-1532
Long-term therapy of chronic hepatitis B with lamivudine
Authors: Lu, DTY Khokhar, MF Doo, E Ghany, MG Herion, D Park, Y Kleiner, DE Schmid, P Condreay, LD Gauthier, J Kuhns, MC Liang, TJ Hoofnagle, JH
Citation: Dty. Lu et al., Long-term therapy of chronic hepatitis B with lamivudine, HEPATOLOGY, 32(4), 2000, pp. 828-834
"Screening for Hemochromatosis," (vol 31, pg 1192, 2000)
Authors: Hunt, CM McGill, JM Allen, MI Condreay, LD
Citation: Cm. Hunt et al., "Screening for Hemochromatosis," (vol 31, pg 1192, 2000), HEPATOLOGY, 32(1), 2000, pp. 160-160
Clinical relevance of hepatitis B viral mutations
Authors: Hunt, CM McGill, JM Allen, MI Condreay, LD
Citation: Cm. Hunt et al., Clinical relevance of hepatitis B viral mutations, HEPATOLOGY, 31(5), 2000, pp. 1037-1044
Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B
Authors: Villeneuve, JP Condreay, LD Willems, B Pomier-Layrargues, G Fenyves, D Bilodeau, M Leduc, R Peltekian, K Wong, F Margulies, M Heathcote, EJ
Citation: Jp. Villeneuve et al., Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B, HEPATOLOGY, 31(1), 2000, pp. 207-210
Combination therapy with lamivudine and adenovirus causes transient suppression of chronic woodchuck hepatitis virus infections
Authors: Zhou, TL Guo, JT Nunes, FA Molnar-Kimber, KL Wilson, JM Aldrich, CE Saputelli, J Litwin, S Condreay, LD Seeger, C Mason, WS
Citation: Tl. Zhou et al., Combination therapy with lamivudine and adenovirus causes transient suppression of chronic woodchuck hepatitis virus infections, J VIROLOGY, 74(24), 2000, pp. 11754-11763
Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation
Authors: Tillmann, HL Trautwein, C Bock, T Boker, KHW Jackel, E Glowienka, M Oldhafer, K Bruns, I Gauthier, J Condreay, LD Raab, HR Manns, MP
Citation: Hl. Tillmann et al., Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation, HEPATOLOGY, 30(1), 1999, pp. 244-256
Two sensitive PCR-based methods for detection of hepatitis B virus variants associated with reduced susceptibility to lamivudine
Authors: Allen, MI Gauthier, J DesLauriers, M Bourne, EJ Carrick, KM Baldanti, F Ross, LL Lutz, MW Condreay, LD
Citation: Mi. Allen et al., Two sensitive PCR-based methods for detection of hepatitis B virus variants associated with reduced susceptibility to lamivudine, J CLIN MICR, 37(10), 1999, pp. 3338-3347
Emergence of drug-resistant populations of woodchuck hepatitis virus in woodchucks treated with the antiviral nucleoside lamivudine
Authors: Zhou, TL Saputelli, J Aldrich, CE Deslauriers, M Condreay, LD Mason, WS
Citation: Tl. Zhou et al., Emergence of drug-resistant populations of woodchuck hepatitis virus in woodchucks treated with the antiviral nucleoside lamivudine, ANTIM AG CH, 43(8), 1999, pp. 1947-1954
Lamivudine as initial treatment for chronic hepatitis B in the United States
Authors: Dienstag, JL Schiff, ER Wright, TL Perrillo, RP Hann, HWL Goodman, Z Crowther, L Condreay, LD Woessner, M Rubin, M Brown, NA
Citation: Jl. Dienstag et al., Lamivudine as initial treatment for chronic hepatitis B in the United States, N ENG J MED, 341(17), 1999, pp. 1256-1263
Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine
Authors: Gauthier, J Bourne, EJ Lutz, MW Crowther, LM Dienstag, JL Brown, NA Condreay, LD
Citation: J. Gauthier et al., Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine, J INFEC DIS, 180(6), 1999, pp. 1757-1762
Antiviral therapy for chronic hepadnavirus infections
Authors: Mason, WS Zhou, TL Nunes, F Condreay, LD Litwin, S Summers, J
Citation: Ws. Mason et al., Antiviral therapy for chronic hepadnavirus infections, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 177-184
Risultati: 1-12 |